also indicated that lipocalin2 may be an important negative regulator in EMT, invasion and metastasis of CRC via acting as upstream of NF-κB/snail signaling pathway, and combinative manipulation of lipocalin2 and NF-κB/snail pathway may represent a novel and promising therapeutic approach for CRC (86). The gene discussed is SNAI1; the disease is colorectal carcinoma.